119 related articles for article (PubMed ID: 35510773)
1. Comparison of Different Hepatocyte Nuclear Factor 4α Clones for Invasive Mucinous Adenocarcinoma of the Lung.
Hsia Y; Huang HC; Chang WC
Appl Immunohistochem Mol Morphol; 2022 May-Jun 01; 30(5):383-388. PubMed ID: 35510773
[TBL] [Abstract][Full Text] [Related]
2. The HNF4α-BC200-FMR1-Positive Feedback Loop Promotes Growth and Metastasis in Invasive Mucinous Lung Adenocarcinoma.
Chen X; Zhao Y; Wang D; Lin Y; Hou J; Xu X; Wu J; Zhong L; Zhou Y; Shen J; Zhang W; Cao H; Hong X; Hu T; Zhan YY
Cancer Res; 2021 Dec; 81(23):5904-5918. PubMed ID: 34654723
[TBL] [Abstract][Full Text] [Related]
3. The predominant expression of hepatocyte nuclear factor 4α (HNF4α) in thyroid transcription factor-1 (TTF-1)-negative pulmonary adenocarcinoma.
Kunii R; Jiang S; Hasegawa G; Yamamoto T; Umezu H; Watanabe T; Tsuchida M; Hashimoto T; Hamakubo T; Kodama T; Sasai K; Naito M
Histopathology; 2011 Feb; 58(3):467-76. PubMed ID: 21348892
[TBL] [Abstract][Full Text] [Related]
4. GATA6-positive lung adenocarcinomas are associated with invasive mucinous adenocarcinoma morphology, hepatocyte nuclear factor 4α expression, and KRAS mutations.
Nakajima N; Yoshizawa A; Nakajima T; Hirata M; Furuhata A; Sumiyoshi S; Rokutan-Kurata M; Sonobe M; Menju T; Miyamoto E; Chen-Yoshikawa TF; Date H; Haga H
Histopathology; 2018 Jul; 73(1):38-48. PubMed ID: 29469192
[TBL] [Abstract][Full Text] [Related]
5. HNF4α as a marker for invasive mucinous adenocarcinoma of the lung.
Sugano M; Nagasaka T; Sasaki E; Murakami Y; Hosoda W; Hida T; Mitsudomi T; Yatabe Y
Am J Surg Pathol; 2013 Feb; 37(2):211-8. PubMed ID: 23108025
[TBL] [Abstract][Full Text] [Related]
6. Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers.
Duruisseaux M; Antoine M; Rabbe N; Rodenas A; Mc Leer-Florin A; Lacave R; Poulot V; Duchêne B; Van Seuningen I; Cadranel J; Wislez M
Lung Cancer; 2017 Jul; 109():92-100. PubMed ID: 28577958
[TBL] [Abstract][Full Text] [Related]
7. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.
Lee HY; Cha MJ; Lee KS; Lee HY; Kwon OJ; Choi JY; Kim HK; Choi YS; Kim J; Shim YM
J Thorac Oncol; 2016 Jul; 11(7):1064-73. PubMed ID: 27016260
[TBL] [Abstract][Full Text] [Related]
8. Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma.
Cui D; Xie S; Liu Q
BMC Pulm Med; 2023 Jan; 23(1):9. PubMed ID: 36624430
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of hepatocyte nuclear factor-4α in vertebrates.
Jiang S; Tanaka T; Yagami R; Hasegawa G; Umezu H; Fujiyoshi Y; Kodama T; Naito M; Ajioka Y
Microsc Res Tech; 2021 Dec; 84(12):2906-2914. PubMed ID: 34196449
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma.
Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1837-45. PubMed ID: 27342421
[TBL] [Abstract][Full Text] [Related]
11. Clinical course of stage IV invasive mucinous adenocarcinoma of the lung.
Cha YJ; Kim HR; Lee HJ; Cho BC; Shim HS
Lung Cancer; 2016 Dec; 102():82-88. PubMed ID: 27987593
[TBL] [Abstract][Full Text] [Related]
12. A distinctive cytomorphological feature of interstitial pneumonia-related lung adenocarcinoma: The potential issues and solutions in practical diagnosis.
Sugiyama M; Matsumura M; Sekiya M; Honda E; Sekine A; Arai H; Okudela K
Cancer Cytopathol; 2023 Mar; 131(3):198-206. PubMed ID: 36508332
[TBL] [Abstract][Full Text] [Related]
13. A subpopulation of airway epithelial cells that express hepatocyte nuclear factor 4α - its implication in the development of non-terminal respiratory unit-type lung adenocarcinoma.
Okudela K; Arai H; Kitamura H; Baba T; Mitsui H; Suzuki T; Sugiyama M; Honda E; Matsumura M; Takemura T; Kataoka T; Koike C; Tateshi Y; Tajiri M; Ogura T; Ohashi K
Histol Histopathol; 2019 Nov; 34(11):1217-1227. PubMed ID: 30848476
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma.
Matsui T; Sakakura N; Koyama S; Nakanishi K; Sasaki E; Kato S; Hosoda W; Murakami Y; Kuroda H; Yatabe Y
Ann Thorac Surg; 2021 Oct; 112(4):1118-1126. PubMed ID: 33242433
[TBL] [Abstract][Full Text] [Related]
15. Anaplastic lymphoma kinase fusion protein expression is associated with a favorable prognosis in resected invasive mucinous lung adenocarcinoma: A retrospective study from two Chinese tertiary hospitals.
Wang J; Wei P; Liu J; Su P; Xing A; Jing H; Hao J
J Cancer Res Ther; 2022 Apr; 18(2):445-451. PubMed ID: 35645113
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary invasive mucinous adenocarcinoma.
Chang WC; Zhang YZ; Nicholson AG
Histopathology; 2024 Jan; 84(1):18-31. PubMed ID: 37867404
[TBL] [Abstract][Full Text] [Related]
17. Primary Invasive Mucinous Adenocarcinoma of the Lung: Prognostic Value of CT Imaging Features Combined with Clinical Factors.
Wang T; Yang Y; Liu X; Deng J; Wu J; Hou L; Wu C; She Y; Sun X; Xie D; Chen C
Korean J Radiol; 2021 Apr; 22(4):652-662. PubMed ID: 33236544
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
Tanaka T; Jiang S; Hotta H; Takano K; Iwanari H; Sumi K; Daigo K; Ohashi R; Sugai M; Ikegame C; Umezu H; Hirayama Y; Midorikawa Y; Hippo Y; Watanabe A; Uchiyama Y; Hasegawa G; Reid P; Aburatani H; Hamakubo T; Sakai J; Naito M; Kodama T
J Pathol; 2006 Apr; 208(5):662-72. PubMed ID: 16400631
[TBL] [Abstract][Full Text] [Related]
19. Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis.
Oshima T; Kawasaki T; Ohashi R; Hasegawa G; Jiang S; Umezu H; Aoyagi Y; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2007 Feb; 57(2):82-90. PubMed ID: 17300672
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
